Prelude Therapeutics Incorporated
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 10 →Insiders5 insiders bought $25.0M in 4 open-market buys. No sales.→HoldersOrbimed 21.8%Baker Bros 16.1%Ra 10.3%→Financing →PeersClosest companies: RVMD, IKT, PMVP→
From the filings
Figures
- Revenue
- $22.4Mlast 12 months
- Net income
- −$60.5Mlast 12 months
- Operating cash flow
- −$43.8Mlast 12 months
- Cash and equivalents
- $26.3Mat the last balance sheet
- Shares outstanding
- 63.0M shareson issue